Abstract
Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable comparisons of health loss over time and across causes, age-sex groups, and countries. The GBD can be used to generate summary measures such as disability-adjusted life-years (DALYs) and healthy life expectancy (HALE) that make possible comparative assessments of broad epidemiological patterns across countries and time. These summary measures can also be used to quantify the component of variation in epidemiology that is related to sociodemographic development. Methods We used the published GBD 2013 data for age-specific mortality, years of life lost due to premature mortality (YLLs), and years lived with disability (YLDs) to calculate DALYs and HALE for 1990, 1995, 2000, 2005, 2010, and 2013 for 188 countries. We calculated HALE using the Sullivan method; 95% uncertainty intervals (UIs) represent uncertainty in age-specific death rates and YLDs per person for each country, age, sex, and year. We estimated DALYs for 306 causes for each country as the sum of YLLs and YLDs; 95% UIs represent uncertainty in YLL and YLD rates. We quantified patterns of the epidemiological transition with a composite indicator of sociodemographic status, which we constructed from income per person, average years of schooling after age 15 years, and the total fertility rate and mean age of the population. We applied hierarchical regression to DALY rates by cause across countries to decompose variance related to the sociodemographic status variable, country, and time. Findings Worldwide, from 1990 to 2013, life expectancy at birth rose by 6·2 years (95% UI 5·6-6·6), from 65·3 years (65·0-65·6) in 1990 to 71·5 years (71·0-71·9) in 2013, HALE at birth rose by 5·4 years (4·9-5·8), from 56·9 years (54·5-59·1) to 62·3 years (59·7-64·8), total DALYs fell by 3·6% (0·3-7·4), and age-standardised DALY rates per 100 000 people fell by 26·7% (24·6-29·1). For communicable, maternal, neonatal, and nutritional disorders, global DALY numbers, crude rates, and age-standardised rates have all declined between 1990 and 2013, whereas for non-communicable diseases, global DALYs have been increasing, DALY rates have remained nearly constant, and age-standardised DALY rates declined during the same period. From 2005 to 2013, the number of DALYs increased for most specific non-communicable diseases, including cardiovascular diseases and neoplasms, in addition to dengue, food-borne trematodes, and leishmaniasis; DALYs decreased for nearly all other causes. By 2013, the five leading causes of DALYs were ischaemic heart disease, lower respiratory infections, cerebrovascular disease, low back and neck pain, and road injuries. Sociodemographic status explained more than 50% of the variance between countries and over time for diarrhoea, lower respiratory infections, and other common infectious diseases; maternal disorders; neonatal disorders; nutritional deficiencies; other communicable, maternal, neonatal, and nutritional diseases; musculoskeletal disorders; and other non-communicable diseases. However, sociodemographic status explained less than 10% of the variance in DALY rates for cardiovascular diseases; chronic respiratory diseases; cirrhosis; diabetes, urogenital, blood, and endocrine diseases; unintentional injuries; and self-harm and interpersonal violence. Predictably, increased sociodemographic status was associated with a shift in burden from YLLs to YLDs, driven by declines in YLLs and increases in YLDs from musculoskeletal disorders, neurological disorders, and mental and substance use disorders. In most country-specific estimates, the increase in life expectancy was greater than that in HALE. Leading causes of DALYs are highly variable across countries. Interpretation Global health is improving. Population growth and ageing have driven up numbers of DALYs, but crude rates have remained relatively constant, showing that progress in health does not mean fewer demands on health systems. The notion of an epidemiological transition - in which increasing sociodemographic status brings structured change in disease burden - is useful, but there is tremendous variation in burden of disease that is not associated with sociodemographic status. This further underscores the need for country-specific assessments of DALYs and HALE to appropriately inform health policy decisions and attendant actions.
Original language | English |
---|---|
Journal | The Lancet |
Volume | 386 |
Issue number | 10009 |
Pages (from-to) | 2145-2191 |
Number of pages | 47 |
ISSN | 0140-6736 |
DOIs | |
Publication status | Published - 28 Nov 2015 |
Keywords
- Aged
- Chronic Disease
- Communicable Diseases
- Female
- Global Health
- Health Transition
- Humans
- Life Expectancy
- Male
- Middle Aged
- Mortality, Premature
- Quality-Adjusted Life Years
- Socioeconomic Factors
- Wounds and Injuries
Access to Document
Fingerprint
Dive into the research topics of 'Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013 : quantifying the epidemiological transition. / Murray, Christopher J L; Barber, Ryan M; Foreman, Kyle J et al.
In: The Lancet, Vol. 386, No. 10009, 28.11.2015, p. 2145-2191.Research output: Contribution to journal › Journal article › Research › peer-review
}
TY - JOUR
T1 - Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013
T2 - quantifying the epidemiological transition
AU - Murray, Christopher J L
AU - Barber, Ryan M
AU - Foreman, Kyle J
AU - Abbasoglu Ozgoren, Ayse
AU - Abd-Allah, Foad
AU - Abera, Semaw F
AU - Aboyans, Victor
AU - Abraham, Jerry P
AU - Abubakar, Ibrahim
AU - Abu-Raddad, Laith J
AU - Abu-Rmeileh, Niveen M
AU - Achoki, Tom
AU - Ackerman, Ilana N
AU - Ademi, Zanfina
AU - Adou, Arsène K
AU - Adsuar, José C
AU - Afshin, Ashkan
AU - Agardh, Emilie E
AU - Alam, Sayed Saidul
AU - Alasfoor, Deena
AU - Albittar, Mohammed I
AU - Alegretti, Miguel A
AU - Alemu, Zewdie A
AU - Alfonso-Cristancho, Rafael
AU - Alhabib, Samia
AU - Ali, Raghib
AU - Alla, François
AU - Allebeck, Peter
AU - Almazroa, Mohammad A
AU - Alsharif, Ubai
AU - Alvarez, Elena
AU - Alvis-Guzman, Nelson
AU - Amare, Azmeraw T
AU - Ameh, Emmanuel A
AU - Amini, Heresh
AU - Ammar, Walid
AU - Anderson, H Ross
AU - Anderson, Benjamin O
AU - Antonio, Carl Abelardo T
AU - Anwari, Palwasha
AU - Arnlöv, Johan
AU - Arsic Arsenijevic, Valentina S
AU - Artaman, Al
AU - Asghar, Rana J
AU - Assadi, Reza
AU - Atkins, Lydia S
AU - Avila, Marco A
AU - Awuah, Baffour
AU - Bachman, Victoria F
AU - Badawi, Alaa
AU - Bahit, Maria C
AU - Balakrishnan, Kalpana
AU - Banerjee, Amitava
AU - Barker-Collo, Suzanne L
AU - Barquera, Simon
AU - Barregard, Lars
AU - Barrero, Lope H
AU - Basu, Arindam
AU - Basu, Sanjay
AU - Basulaiman, Mohammed O
AU - Beardsley, Justin
AU - Bedi, Neeraj
AU - Beghi, Ettore
AU - Bekele, Tolesa
AU - Bell, Michelle L
AU - Benjet, Corina
AU - Bennett, Derrick A
AU - Bensenor, Isabela M
AU - Benzian, Habib
AU - Bernabé, Eduardo
AU - Bertozzi-Villa, Amelia
AU - Beyene, Tariku J
AU - Bhala, Neeraj
AU - Bhalla, Ashish
AU - Bhutta, Zulfiqar A
AU - Bienhoff, Kelly
AU - Bikbov, Boris
AU - Biryukov, Stan
AU - Blore, Jed D
AU - Blosser, Christopher D
AU - Blyth, Fiona M
AU - Bohensky, Megan A
AU - Bolliger, Ian W
AU - Bora Başara, Berrak
AU - Bornstein, Natan M
AU - Bose, Dipan
AU - Boufous, Soufiane
AU - Bourne, Rupert R A
AU - Boyers, Lindsay N
AU - Brainin, Michael
AU - Brayne, Carol E
AU - Brazinova, Alexandra
AU - Breitborde, Nicholas J K
AU - Brenner, Hermann
AU - Briggs, Adam D
AU - Brooks, Peter
AU - Brown, Jonathan C
AU - Brugha, Traolach S
AU - Buchbinder, Rachelle
AU - Buckle, Geoffrey C
AU - Budke, Christine M
AU - Bulchis, Anne
AU - Bulloch, Andrew G
AU - Campos-Nonato, Ismael R
AU - Carabin, Hélène
AU - Carapetis, Jonathan R
AU - Cárdenas, Rosario
AU - Carpenter, David O
AU - Caso, Valeria
AU - Castañeda-Orjuela, Carlos A
AU - Castro, Ruben E
AU - Catalá-López, Ferrán
AU - Cavalleri, Fiorella
AU - Çavlin, Alanur
AU - Chadha, Vineet K
AU - Chang, Jung-Chen
AU - Charlson, Fiona J
AU - Chen, Honglei
AU - Chen, Wanqing
AU - Chiang, Peggy P
AU - Chimed-Ochir, Odgerel
AU - Chowdhury, Rajiv
AU - Christensen, Hanne
AU - Christophi, Costas A
AU - Cirillo, Massimo
AU - Coates, Matthew M
AU - Coffeng, Luc E
AU - Coggeshall, Megan S
AU - Colistro, Valentina
AU - Colquhoun, Samantha M
AU - Cooke, Graham S
AU - Cooper, Cyrus
AU - Cooper, Leslie T
AU - Coppola, Luis M
AU - Cortinovis, Monica
AU - Criqui, Michael H
AU - Crump, John A
AU - Cuevas-Nasu, Lucia
AU - Danawi, Hadi
AU - Dandona, Lalit
AU - Dandona, Rakhi
AU - Dansereau, Emily
AU - Dargan, Paul I
AU - Davey, Gail
AU - Davis, Adrian
AU - Davitoiu, Dragos V
AU - Dayama, Anand
AU - De Leo, Diego
AU - Degenhardt, Louisa
AU - Del Pozo-Cruz, Borja
AU - Dellavalle, Robert P
AU - Deribe, Kebede
AU - Derrett, Sarah
AU - Des Jarlais, Don C
AU - Dessalegn, Muluken
AU - Dharmaratne, Samath D
AU - Dherani, Mukesh K
AU - Diaz-Torné, Cesar
AU - Dicker, Daniel
AU - Ding, Eric L
AU - Dokova, Klara
AU - Dorsey, E Ray
AU - Driscoll, Tim R
AU - Duan, Leilei
AU - Duber, Herbert C
AU - Ebel, Beth E
AU - Edmond, Karen M
AU - Elshrek, Yousef M
AU - Endres, Matthias
AU - Ermakov, Sergey P
AU - Erskine, Holly E
AU - Eshrati, Babak
AU - Esteghamati, Alireza
AU - Estep, Kara
AU - Faraon, Emerito Jose A
AU - Farzadfar, Farshad
AU - Fay, Derek F
AU - Feigin, Valery L
AU - Felson, David T
AU - Fereshtehnejad, Seyed-Mohammad
AU - Fernandes, Jefferson G
AU - Ferrari, Alize J
AU - Fitzmaurice, Christina
AU - Flaxman, Abraham D
AU - Fleming, Thomas D
AU - Foigt, Nataliya
AU - Forouzanfar, Mohammad H
AU - Fowkes, F Gerry R
AU - Paleo, Urbano Fra
AU - Franklin, Richard C
AU - Fürst, Thomas
AU - Gabbe, Belinda
AU - Gaffikin, Lynne
AU - Gankpé, Fortuné G
AU - Geleijnse, Johanna M
AU - Gessner, Bradford D
AU - Gething, Peter
AU - Gibney, Katherine B
AU - Giroud, Maurice
AU - Giussani, Giorgia
AU - Gomez Dantes, Hector
AU - Gona, Philimon
AU - González-Medina, Diego
AU - Gosselin, Richard A
AU - Gotay, Carolyn C
AU - Goto, Atsushi
AU - Gouda, Hebe N
AU - Graetz, Nicholas
AU - Gugnani, Harish C
AU - Gupta, Rahul
AU - Gupta, Rajeev
AU - Gutiérrez, Reyna A
AU - Haagsma, Juanita
AU - Hafezi-Nejad, Nima
AU - Hagan, Holly
AU - Halasa, Yara A
AU - Hamadeh, Randah R
AU - Hamavid, Hannah
AU - Hammami, Mouhanad
AU - Hancock, Jamie
AU - Hankey, Graeme J
AU - Hansen, Gillian M
AU - Hao, Yuantao
AU - Harb, Hilda L
AU - Haro, Josep Maria
AU - Havmøller, Rasmus
AU - Hay, Simon I
AU - Hay, Roderick J
AU - Heredia-Pi, Ileana B
AU - Heuton, Kyle R
AU - Heydarpour, Pouria
AU - Higashi, Hideki
AU - Hijar, Martha
AU - Hoek, Hans W
AU - Hoffman, Howard J
AU - Hosgood, H Dean
AU - Hossain, Mazeda
AU - Hotez, Peter J
AU - Hoy, Damian G
AU - Hsairi, Mohamed
AU - Hu, Guoqing
AU - Huang, Cheng
AU - Huang, John J
AU - Husseini, Abdullatif
AU - Huynh, Chantal
AU - Iannarone, Marissa L
AU - Iburg, Kim Moesgaard
AU - Innos, Kaire
AU - Inoue, Manami
AU - Islami, Farhad
AU - Jacobsen, Kathryn H
AU - Jarvis, Deborah L
AU - Jassal, Simerjot K
AU - Jee, Sun Ha
AU - Jeemon, Panniyammakal
AU - Jensen, Paul N
AU - Jha, Vivekanand
AU - Jiang, Guohong
AU - Jiang, Ying
AU - Jonas, Jost B
AU - Juel, Knud
AU - Kan, Haidong
AU - Karch, André
AU - Karema, Corine K
AU - Karimkhani, Chante
AU - Karthikeyan, Ganesan
AU - Kassebaum, Nicholas J
AU - Kaul, Anil
AU - Kawakami, Norito
AU - Kazanjan, Konstantin
AU - Kemp, Andrew H
AU - Kengne, Andre P
AU - Keren, Andre
AU - Khader, Yousef S
AU - Khalifa, Shams Eldin A
AU - Khan, Ejaz A
AU - Khan, Gulfaraz
AU - Khang, Young-Ho
AU - Kieling, Christian
AU - Kim, Daniel
AU - Kim, Sungroul
AU - Kim, Yunjin
AU - Kinfu, Yohannes
AU - Kinge, Jonas M
AU - Kivipelto, Miia
AU - Knibbs, Luke D
AU - Knudsen, Ann Kristin
AU - Kokubo, Yoshihiro
AU - Kosen, Soewarta
AU - Krishnaswami, Sanjay
AU - Kuate Defo, Barthelemy
AU - Kucuk Bicer, Burcu
AU - Kuipers, Ernst J
AU - Kulkarni, Chanda
AU - Kulkarni, Veena S
AU - Kumar, G Anil
AU - Kyu, Hmwe H
AU - Lai, Taavi
AU - Lalloo, Ratilal
AU - Lallukka, Tea
AU - Lam, Hilton
AU - Lan, Qing
AU - Lansingh, Van C
AU - Larsson, Anders
AU - Lawrynowicz, Alicia E B
AU - Leasher, Janet L
AU - Leigh, James
AU - Leung, Ricky
AU - Levitz, Carly E
AU - Li, Bin
AU - Li, Yichong
AU - Li, Yongmei
AU - Lim, Stephen S
AU - Lind, Maggie
AU - Lipshultz, Steven E
AU - Liu, Shiwei
AU - Liu, Yang
AU - Lloyd, Belinda K
AU - Lofgren, Katherine T
AU - Logroscino, Giancarlo
AU - Looker, Katharine J
AU - Lortet-Tieulent, Joannie
AU - Lotufo, Paulo A
AU - Lozano, Rafael
AU - Lucas, Robyn M
AU - Lunevicius, Raimundas
AU - Lyons, Ronan A
AU - Ma, Stefan
AU - Macintyre, Michael F
AU - Mackay, Mark T
AU - Majdan, Marek
AU - Malekzadeh, Reza
AU - Marcenes, Wagner
AU - Margolis, David J
AU - Margono, Christopher
AU - Marzan, Melvin B
AU - Masci, Joseph R
AU - Mashal, Mohammad T
AU - Matzopoulos, Richard
AU - Mayosi, Bongani M
AU - Mazorodze, Tasara T
AU - Mcgill, Neil W
AU - Mcgrath, John J
AU - Mckee, Martin
AU - Mclain, Abigail
AU - Meaney, Peter A
AU - Medina, Catalina
AU - Mehndiratta, Man Mohan
AU - Mekonnen, Wubegzier
AU - Melaku, Yohannes A
AU - Meltzer, Michele
AU - Memish, Ziad A
AU - Mensah, George A
AU - Meretoja, Atte
AU - Mhimbira, Francis A
AU - Micha, Renata
AU - Miller, Ted R
AU - Mills, Edward J
AU - Mitchell, Philip B
AU - Mock, Charles N
AU - Mohamed Ibrahim, Norlinah
AU - Mohammad, Karzan A
AU - Mokdad, Ali H
AU - Mola, Glen L D
AU - Monasta, Lorenzo
AU - Montañez Hernandez, Julio C
AU - Montico, Marcella
AU - Montine, Thomas J
AU - Mooney, Meghan D
AU - Moore, Ami R
AU - Moradi-Lakeh, Maziar
AU - Moran, Andrew E
AU - Mori, Rintaro
AU - Moschandreas, Joanna
AU - Moturi, Wilkister N
AU - Moyer, Madeline L
AU - Mozaffarian, Dariush
AU - Msemburi, William T
AU - Mueller, Ulrich O
AU - Mukaigawara, Mitsuru
AU - Mullany, Erin C
AU - Murdoch, Michele E
AU - Murray, Joseph
AU - Murthy, Kinnari S
AU - Naghavi, Mohsen
AU - Naheed, Aliya
AU - Naidoo, Kovin S
AU - Naldi, Luigi
AU - Nand, Devina
AU - Nangia, Vinay
AU - Narayan, K M Venkat
AU - Nejjari, Chakib
AU - Neupane, Sudan P
AU - Newton, Charles R
AU - Ng, Marie
AU - Ngalesoni, Frida N
AU - Nguyen, Grant
AU - Nisar, Muhammad I
AU - Nolte, Sandra
AU - Norheim, Ole F
AU - Norman, Rosana E
AU - Norrving, Bo
AU - Nyakarahuka, Luke
AU - Oh, In-Hwan
AU - Ohkubo, Takayoshi
AU - Ohno, Summer L
AU - Olusanya, Bolajoko O
AU - Opio, John Nelson
AU - Ortblad, Katrina
AU - Ortiz, Alberto
AU - Pain, Amanda W
AU - Pandian, Jeyaraj D
AU - Panelo, Carlo Irwin A
AU - Papachristou, Christina
AU - Park, Eun-Kee
AU - Park, Jae-Hyun
AU - Patten, Scott B
AU - Patton, George C
AU - Paul, Vinod K
AU - Pavlin, Boris I
AU - Pearce, Neil
AU - Pereira, David M
AU - Perez-Padilla, Rogelio
AU - Perez-Ruiz, Fernando
AU - Perico, Norberto
AU - Pervaiz, Aslam
AU - Pesudovs, Konrad
AU - Peterson, Carrie B
AU - Petzold, Max
AU - Phillips, Michael R
AU - Phillips, Bryan K
AU - Phillips, David E
AU - Piel, Frédéric B
AU - Plass, Dietrich
AU - Poenaru, Dan
AU - Polinder, Suzanne
AU - Pope, Daniel
AU - Popova, Svetlana
AU - Poulton, Richie G
AU - Pourmalek, Farshad
AU - Prabhakaran, Dorairaj
AU - Prasad, Noela M
AU - Pullan, Rachel L
AU - Qato, Dima M
AU - Quistberg, D Alex
AU - Rafay, Anwar
AU - Rahimi, Kazem
AU - Rahman, Sajjad U
AU - Raju, Murugesan
AU - Rana, Saleem M
AU - Razavi, Homie
AU - Reddy, K Srinath
AU - Refaat, Amany
AU - Remuzzi, Giuseppe
AU - Resnikoff, Serge
AU - Ribeiro, Antonio L
AU - Richardson, Lee
AU - Richardus, Jan Hendrik
AU - Roberts, D Allen
AU - Rojas-Rueda, David
AU - Ronfani, Luca
AU - Roth, Gregory A
AU - Rothenbacher, Dietrich
AU - Rothstein, David H
AU - Rowley, Jane T
AU - Roy, Nobhojit
AU - Ruhago, George M
AU - Saeedi, Mohammad Y
AU - Saha, Sukanta
AU - Sahraian, Mohammad Ali
AU - Sampson, Uchechukwu K A
AU - Sanabria, Juan R
AU - Sandar, Logan
AU - Santos, Itamar S
AU - Satpathy, Maheswar
AU - Sawhney, Monika
AU - Scarborough, Peter
AU - Schneider, Ione J
AU - Schöttker, Ben
AU - Schumacher, Austin E
AU - Schwebel, David C
AU - Scott, James G
AU - Seedat, Soraya
AU - Sepanlou, Sadaf G
AU - Serina, Peter T
AU - Servan-Mori, Edson E
AU - Shackelford, Katya A
AU - Shaheen, Amira
AU - Shahraz, Saeid
AU - Shamah Levy, Teresa
AU - Shangguan, Siyi
AU - She, Jun
AU - Sheikhbahaei, Sara
AU - Shi, Peilin
AU - Shibuya, Kenji
AU - Shinohara, Yukito
AU - Shiri, Rahman
AU - Shishani, Kawkab
AU - Shiue, Ivy
AU - Shrime, Mark G
AU - Sigfusdottir, Inga D
AU - Silberberg, Donald H
AU - Simard, Edgar P
AU - Sindi, Shireen
AU - Singh, Abhishek
AU - Singh, Jasvinder A
AU - Singh, Lavanya
AU - Skirbekk, Vegard
AU - Slepak, Erica Leigh
AU - Sliwa, Karen
AU - Soneji, Samir
AU - Søreide, Kjetil
AU - Soshnikov, Sergey
AU - Sposato, Luciano A
AU - Sreeramareddy, Chandrashekhar T
AU - Stanaway, Jeffrey D
AU - Stathopoulou, Vasiliki
AU - Stein, Dan J
AU - Stein, Murray B
AU - Steiner, Caitlyn
AU - Steiner, Timothy J
AU - Stevens, Antony
AU - Stewart, Andrea
AU - Stovner, Lars J
AU - Stroumpoulis, Konstantinos
AU - Sunguya, Bruno F
AU - Swaminathan, Soumya
AU - Swaroop, Mamta
AU - Sykes, Bryan L
AU - Tabb, Karen M
AU - Takahashi, Ken
AU - Tandon, Nikhil
AU - Tanne, David
AU - Tanner, Marcel
AU - Tavakkoli, Mohammad
AU - Taylor, Hugh R
AU - Te Ao, Braden J
AU - Tediosi, Fabrizio
AU - Temesgen, Awoke M
AU - Templin, Tara
AU - Ten Have, Margreet
AU - Tenkorang, Eric Y
AU - Terkawi, Abdullah S
AU - Thomson, Blake
AU - Thorne-Lyman, Andrew L
AU - Thrift, Amanda G
AU - Thurston, George D
AU - Tillmann, Taavi
AU - Tonelli, Marcello
AU - Topouzis, Fotis
AU - Toyoshima, Hideaki
AU - Traebert, Jefferson
AU - Tran, Bach X
AU - Trillini, Matias
AU - Truelsen, Thomas
AU - Tsilimbaris, Miltiadis
AU - Tuzcu, Emin M
AU - Uchendu, Uche S
AU - Ukwaja, Kingsley N
AU - Undurraga, Eduardo A
AU - Uzun, Selen B
AU - Van Brakel, Wim H
AU - Van De Vijver, Steven
AU - van Gool, Coen H
AU - Van Os, Jim
AU - Vasankari, Tommi J
AU - Venketasubramanian, N
AU - Violante, Francesco S
AU - Vlassov, Vasiliy V
AU - Vollset, Stein Emil
AU - Wagner, Gregory R
AU - Wagner, Joseph
AU - Waller, Stephen G
AU - Wan, Xia
AU - Wang, Haidong
AU - Wang, Jianli
AU - Wang, Linhong
AU - Warouw, Tati S
AU - Weichenthal, Scott
AU - Weiderpass, Elisabete
AU - Weintraub, Robert G
AU - Wenzhi, Wang
AU - Werdecker, Andrea
AU - Westerman, Ronny
AU - Whiteford, Harvey A
AU - Wilkinson, James D
AU - Williams, Thomas N
AU - Wolfe, Charles D
AU - Wolock, Timothy M
AU - Woolf, Anthony D
AU - Wulf, Sarah
AU - Wurtz, Brittany
AU - Xu, Gelin
AU - Yan, Lijing L
AU - Yano, Yuichiro
AU - Ye, Pengpeng
AU - Yentür, Gökalp K
AU - Yip, Paul
AU - Yonemoto, Naohiro
AU - Yoon, Seok-Jun
AU - Younis, Mustafa Z
AU - Yu, Chuanhua
AU - Zaki, Maysaa E
AU - Zhao, Yong
AU - Zheng, Yingfeng
AU - Zonies, David
AU - Zou, Xiaonong
AU - Salomon, Joshua A
AU - Lopez, Alan D
AU - Vos, Theo
N1 - Copyright © 2015 Elsevier Ltd. All rights reserved.
PY - 2015/11/28
Y1 - 2015/11/28
N2 - Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable comparisons of health loss over time and across causes, age-sex groups, and countries. The GBD can be used to generate summary measures such as disability-adjusted life-years (DALYs) and healthy life expectancy (HALE) that make possible comparative assessments of broad epidemiological patterns across countries and time. These summary measures can also be used to quantify the component of variation in epidemiology that is related to sociodemographic development. Methods We used the published GBD 2013 data for age-specific mortality, years of life lost due to premature mortality (YLLs), and years lived with disability (YLDs) to calculate DALYs and HALE for 1990, 1995, 2000, 2005, 2010, and 2013 for 188 countries. We calculated HALE using the Sullivan method; 95% uncertainty intervals (UIs) represent uncertainty in age-specific death rates and YLDs per person for each country, age, sex, and year. We estimated DALYs for 306 causes for each country as the sum of YLLs and YLDs; 95% UIs represent uncertainty in YLL and YLD rates. We quantified patterns of the epidemiological transition with a composite indicator of sociodemographic status, which we constructed from income per person, average years of schooling after age 15 years, and the total fertility rate and mean age of the population. We applied hierarchical regression to DALY rates by cause across countries to decompose variance related to the sociodemographic status variable, country, and time. Findings Worldwide, from 1990 to 2013, life expectancy at birth rose by 6·2 years (95% UI 5·6-6·6), from 65·3 years (65·0-65·6) in 1990 to 71·5 years (71·0-71·9) in 2013, HALE at birth rose by 5·4 years (4·9-5·8), from 56·9 years (54·5-59·1) to 62·3 years (59·7-64·8), total DALYs fell by 3·6% (0·3-7·4), and age-standardised DALY rates per 100 000 people fell by 26·7% (24·6-29·1). For communicable, maternal, neonatal, and nutritional disorders, global DALY numbers, crude rates, and age-standardised rates have all declined between 1990 and 2013, whereas for non-communicable diseases, global DALYs have been increasing, DALY rates have remained nearly constant, and age-standardised DALY rates declined during the same period. From 2005 to 2013, the number of DALYs increased for most specific non-communicable diseases, including cardiovascular diseases and neoplasms, in addition to dengue, food-borne trematodes, and leishmaniasis; DALYs decreased for nearly all other causes. By 2013, the five leading causes of DALYs were ischaemic heart disease, lower respiratory infections, cerebrovascular disease, low back and neck pain, and road injuries. Sociodemographic status explained more than 50% of the variance between countries and over time for diarrhoea, lower respiratory infections, and other common infectious diseases; maternal disorders; neonatal disorders; nutritional deficiencies; other communicable, maternal, neonatal, and nutritional diseases; musculoskeletal disorders; and other non-communicable diseases. However, sociodemographic status explained less than 10% of the variance in DALY rates for cardiovascular diseases; chronic respiratory diseases; cirrhosis; diabetes, urogenital, blood, and endocrine diseases; unintentional injuries; and self-harm and interpersonal violence. Predictably, increased sociodemographic status was associated with a shift in burden from YLLs to YLDs, driven by declines in YLLs and increases in YLDs from musculoskeletal disorders, neurological disorders, and mental and substance use disorders. In most country-specific estimates, the increase in life expectancy was greater than that in HALE. Leading causes of DALYs are highly variable across countries. Interpretation Global health is improving. Population growth and ageing have driven up numbers of DALYs, but crude rates have remained relatively constant, showing that progress in health does not mean fewer demands on health systems. The notion of an epidemiological transition - in which increasing sociodemographic status brings structured change in disease burden - is useful, but there is tremendous variation in burden of disease that is not associated with sociodemographic status. This further underscores the need for country-specific assessments of DALYs and HALE to appropriately inform health policy decisions and attendant actions.
AB - Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together all available epidemiological data using a coherent measurement framework, standardised estimation methods, and transparent data sources to enable comparisons of health loss over time and across causes, age-sex groups, and countries. The GBD can be used to generate summary measures such as disability-adjusted life-years (DALYs) and healthy life expectancy (HALE) that make possible comparative assessments of broad epidemiological patterns across countries and time. These summary measures can also be used to quantify the component of variation in epidemiology that is related to sociodemographic development. Methods We used the published GBD 2013 data for age-specific mortality, years of life lost due to premature mortality (YLLs), and years lived with disability (YLDs) to calculate DALYs and HALE for 1990, 1995, 2000, 2005, 2010, and 2013 for 188 countries. We calculated HALE using the Sullivan method; 95% uncertainty intervals (UIs) represent uncertainty in age-specific death rates and YLDs per person for each country, age, sex, and year. We estimated DALYs for 306 causes for each country as the sum of YLLs and YLDs; 95% UIs represent uncertainty in YLL and YLD rates. We quantified patterns of the epidemiological transition with a composite indicator of sociodemographic status, which we constructed from income per person, average years of schooling after age 15 years, and the total fertility rate and mean age of the population. We applied hierarchical regression to DALY rates by cause across countries to decompose variance related to the sociodemographic status variable, country, and time. Findings Worldwide, from 1990 to 2013, life expectancy at birth rose by 6·2 years (95% UI 5·6-6·6), from 65·3 years (65·0-65·6) in 1990 to 71·5 years (71·0-71·9) in 2013, HALE at birth rose by 5·4 years (4·9-5·8), from 56·9 years (54·5-59·1) to 62·3 years (59·7-64·8), total DALYs fell by 3·6% (0·3-7·4), and age-standardised DALY rates per 100 000 people fell by 26·7% (24·6-29·1). For communicable, maternal, neonatal, and nutritional disorders, global DALY numbers, crude rates, and age-standardised rates have all declined between 1990 and 2013, whereas for non-communicable diseases, global DALYs have been increasing, DALY rates have remained nearly constant, and age-standardised DALY rates declined during the same period. From 2005 to 2013, the number of DALYs increased for most specific non-communicable diseases, including cardiovascular diseases and neoplasms, in addition to dengue, food-borne trematodes, and leishmaniasis; DALYs decreased for nearly all other causes. By 2013, the five leading causes of DALYs were ischaemic heart disease, lower respiratory infections, cerebrovascular disease, low back and neck pain, and road injuries. Sociodemographic status explained more than 50% of the variance between countries and over time for diarrhoea, lower respiratory infections, and other common infectious diseases; maternal disorders; neonatal disorders; nutritional deficiencies; other communicable, maternal, neonatal, and nutritional diseases; musculoskeletal disorders; and other non-communicable diseases. However, sociodemographic status explained less than 10% of the variance in DALY rates for cardiovascular diseases; chronic respiratory diseases; cirrhosis; diabetes, urogenital, blood, and endocrine diseases; unintentional injuries; and self-harm and interpersonal violence. Predictably, increased sociodemographic status was associated with a shift in burden from YLLs to YLDs, driven by declines in YLLs and increases in YLDs from musculoskeletal disorders, neurological disorders, and mental and substance use disorders. In most country-specific estimates, the increase in life expectancy was greater than that in HALE. Leading causes of DALYs are highly variable across countries. Interpretation Global health is improving. Population growth and ageing have driven up numbers of DALYs, but crude rates have remained relatively constant, showing that progress in health does not mean fewer demands on health systems. The notion of an epidemiological transition - in which increasing sociodemographic status brings structured change in disease burden - is useful, but there is tremendous variation in burden of disease that is not associated with sociodemographic status. This further underscores the need for country-specific assessments of DALYs and HALE to appropriately inform health policy decisions and attendant actions.
KW - Aged
KW - Chronic Disease
KW - Communicable Diseases
KW - Female
KW - Global Health
KW - Health Transition
KW - Humans
KW - Life Expectancy
KW - Male
KW - Middle Aged
KW - Mortality, Premature
KW - Quality-Adjusted Life Years
KW - Socioeconomic Factors
KW - Wounds and Injuries
U2 - 10.1016/S0140-6736(15)61340-X
DO - 10.1016/S0140-6736(15)61340-X
M3 - Journal article
C2 - 26321261
SN - 0140-6736
VL - 386
SP - 2145
EP - 2191
JO - Lancet
JF - Lancet
IS - 10009
ER -